Blood substitutes comprising hemoglobin and methods of making
AssigneeVirTech Bio, Inc.
InventorsWilliam Richard Light, Joseph Tucker
Life of this patent
Estimating the term…
Loading patent…
AssigneeVirTech Bio, Inc.
InventorsWilliam Richard Light, Joseph Tucker
Estimating the term…
Methods for making hemoglobin based blood substitute preparations and hemoglobin based blood substitute preparations. The methods involve preparing a low purity erythrocyte protein fraction comprising hemoglobin protein and endogenous non-hemoglobin protein complement, and chemically modifying the proteins in the protein fraction to form a cross-linked hemoglobin containing blood substitute preparation. The low purity erythrocyte protein preparation can contain from at least about 0.2% (mole/mole) up to about 20% (mole/mole) endogenous non-hemoglobin protein complement. At least about 90% (mole/mole) of the hemoglobin proteins can be cross-linked, so that the average molecular mass of cross-linked proteins comprising hemoglobin protein molecules in the preparation is at least about 300 kDa. The preparations can be used to prepare finished blood substitute formulations for in-vivo and ex-vivo use.
A method of preparing a blood substitute preparation comprising hemoglobin, the method comprising:
Dependencies are inferred from the claim text.